Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
André Delacourte
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Anatomy
Phenomena
Procedures
Physiology
Sign-in to see full Profile
Network (preview)
59
BUEE, Luc
38
Sergeant, Nicolas
18
Hof, Patrick
17
Wattez, Annick
16
Vermersch, Patrick
16
Hamdane, Malika
16
Caillet-Boudin, Marie-Laure
13
David, Jean-Philippe
12
Pasquier, Florence
11
Maurage, Claude-Alain
11
Bégard, Séverine
10
Ghestem, Antoine
9
Delobel, Patrice
9
Chartier-Harlin, Marie-Christine
9
Perl, Daniel
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of André Delacourte (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Caparros-Lefebvre Dominique; Kerdraon Olivier; Devos David; Dhaenens C M; Blum David; Maurage C A; Delacourte André; Sablonnière Bernard
Association of corticobasal degeneration and Huntington's disease: can Tau aggregates protect Huntingtin toxicity?
Movement disorders : official journal of the Movement Disorder Society 2009;24(7):1089-90.
-
2009: Rudinskiy Nikita; Grishchuk Yulia; Vaslin Anne; Puyal Julien; Delacourte André; Hirling Harald; Clarke Peter G H; Luthi-Carter Ruth
Calpain hydrolysis of alpha- and beta2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration.
The Journal of biological chemistry 2009;284(18):12447-58.
-
2009: Hébert Sébastien S; Horré Katrien; Nicolaï Laura; Bergmans Bruno; Papadopoulou Aikaterini S; Delacourte André; De Strooper Bart
MicroRNA regulation of Alzheimer's Amyloid precursor protein expression.
Neurobiology of disease 2009;33(3):422-8.
-
2009: Thathiah Amantha; Spittaels Kurt; Hoffmann Marcel; Staes Mik; Cohen Adrian; Horré Katrién; Vanbrabant Mieke; Coun Frea; Baekelandt Veerle; Delacourte André; Fischer David F; Pollet Dirk; De Strooper Bart; Merchiers Pascal
The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons.
Science (New York, N.Y.) 2009;323(5916):946-51.
-
2008: Kashani Alireza; Lepicard Eve; Poirel Odile; Videau Catherine; David Jean Philippe; Fallet-Bianco Catherine; Simon Axelle; Delacourte André; Giros Bruno; Epelbaum Jacques; Betancur Catalina; El Mestikawy Salah
Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.
Neurobiology of aging 2008;29(11):1619-30.
-
2008: Delacourte André
Tau pathology and neurodegeneration: an obvious but misunderstood link.
Journal of Alzheimer's disease : JAD 2008;14(4):437-40.
-
2008: Sergeant Nicolas; Bretteville Alexis; Hamdane Malika; Caillet-Boudin Marie-Laure; Grognet Pierre; Bombois Stephanie; Blum David; Delacourte André; Pasquier Florence; Vanmechelen Eugeen; Schraen-Maschke Susanna; Buée Luc
Biochemistry of Tau in Alzheimer's disease and related neurological disorders.
Expert review of proteomics 2008;5(2):207-24.
-
2008: Hébert Sébastien S; Horré Katrien; Nicolaï Laura; Papadopoulou Aikaterini S; Mandemakers Wim; Silahtaroglu Asli N; Kauppinen Sakari; Delacourte André; De Strooper Bart
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(17):6415-20.
-
2008: Dhaenens C M; Schraen-Maschke S; Tran H; Vingtdeux V; Ghanem D; Leroy O; Delplanque J; Vanbrussel E; Delacourte A; Vermersch P; Maurage C A; Gruffat H; Sergeant A; Mahadevan M S; Ishiura S; Buée L; Cooper T A; Caillet-Boudin M L; Charlet-Berguerand N; Sablonnière B; Sergeant N
Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.
Experimental neurology 2008;210(2):467-78.
-
2008: Delacourte Andre
Tau, a biological marker of neurodegenerative diseases.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2008;89():161-72.
-
2007: Dubois Bruno; Feldman Howard H; Jacova Claudia; Dekosky Steven T; Barberger-Gateau Pascale; Cummings Jeffrey; Delacourte André; Galasko Douglas; Gauthier Serge; Jicha Gregory; Meguro Kenichi; O'brien John; Pasquier Florence; Robert Philippe; Rossor Martin; Salloway Steven; Stern Yaakov; Visser Pieter J; Scheltens Philip
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.
Lancet neurology 2007;6(8):734-46.
-
2007: Cacquevel Mathias; Launay Séverine; Castel Hervé; Benchenane Karim; Chéenne Simon; Buée Luc; Moons Lieve; Delacourte André; Carmeliet Peter; Vivien Denis
Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms.
Neurobiology of disease 2007;27(2):164-73.
-
2007: Vingtdeux Valérie; Hamdane Malika; Loyens Anne; Gelé Patrick; Drobeck Hervé; Bégard Séverine; Galas Marie-Christine; Delacourte André; Beauvillain Jean-Claude; Buée Luc; Sergeant Nicolas
Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies.
The Journal of biological chemistry 2007;282(25):18197-205.
-
2007: Ma Huifang; Lesné Sylvain; Kotilinek Linda; Steidl-Nichols Jill V; Sherman Mathew; Younkin Linda; Younkin Steven; Forster Colleen; Sergeant Nicolas; Delacourte André; Vassar Robert; Citron Martin; Kofuji Paulo; Boland Linda M; Ashe Karen H
Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(19):8167-72.
-
2007: Bombois Stéphanie; Maurage Claude-Alain; Gompel Marie; Deramecourt Vincent; Mackowiak-Cordoliani Marie-Anne; Black Ronald S; Lavielle Rodolphe; Delacourte André; Pasquier Florence
Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia.
Archives of neurology 2007;64(4):583-7.
-
2007: Vingtdeux Valérie; Hamdane Malika; Bégard Séverine; Loyens Anne; Delacourte André; Beauvillain Jean-Claude; Buée Luc; Marambaud Philippe; Sergeant Nicolas
Intracellular pH regulates amyloid precursor protein intracellular domain accumulation.
Neurobiology of disease 2007;25(3):686-96.
-
2007: Boutillier Stéphanie; Lannes Béatrice; Buée Luc; Delacourte André; Rouaux Caroline; Mohr Michel; Bellocq Jean-Pierre; Sellal François; Larmet Yves; Boutillier Anne-Laurence; Loeffler Jean-Philippe
Sp3 and sp4 transcription factor levels are increased in brains of patients with Alzheimer's disease.
Neuro-degenerative diseases 2007;4(6):413-23.
-
2007: Evans Teresa A; Raina Arun K; Delacourte André; Aprelikova Olga; Lee Hyoung-gon; Zhu Xiongwei; Perry George; Smith Mark A
BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease.
International journal of medical sciences 2007;4(3):140-5.
-
2006: Buée Luc; Delacourte André
[Tauopathy and Alzheimer disease: a full degenerating process]
Psychologie & neuropsychiatrie du vieillissement 2006;4(4):261-73.
-
2006: Delacourte A
[From physiopathology to treatment of Alzheimer's disease]
Revue neurologique 2006;162(10):909-12.
-
2006: Leroy Olivier; Dhaenens Claire-Marie; Schraen-Maschke Suzanna; Belarbi Karim; Delacourte André; Andreadis Athena; Sablonnière Bernard; Buée Luc; Sergeant Nicolas; Caillet-Boudin Marie-Laure
ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I.
Journal of neuroscience research 2006;84(4):852-9.
-
2006: Husson Marianne; Enderlin Valérie; Delacourte André; Ghenimi Nadirah; Alfos Serge; Pallet Véronique; Higueret Paul
Retinoic acid normalizes nuclear receptor mediated hypo-expression of proteins involved in beta-amyloid deposits in the cerebral cortex of vitamin A deprived rats.
Neurobiology of disease 2006;23(1):1-10.
-
2006: Hamdane Malika; Dourlen Pierre; Bretteville Alexis; Sambo Anne-Véronique; Ferreira Stéphanie; Ando Kunie; Kerdraon Olivier; Bégard Séverine; Geay Linda; Lippens Guy; Sergeant Nicolas; Delacourte André; Maurage Claude-Alain; Galas Marie-Christine; Buée Luc
Pin1 allows for differential Tau dephosphorylation in neuronal cells.
Molecular and cellular neurosciences 2006;32(1-2):155-60.
-
2006: Deramecourt V; Bombois S; Maurage C-A; Ghestem A; Drobecq H; Vanmechelen E; Lebert F; Pasquier F; Delacourte A
Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
Journal of neuropathology and experimental neurology 2006;65(3):278-88.
-
2006: Delacourte André
The natural and molecular history of Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2006;9(3 Suppl):187-94.
-
2005: Delacourte André; Buée Luc
[Animal models of Alzheimer's disease: a road full of pitfalls]
Psychologie & neuropsychiatrie du vieillissement 2005;3(4):261-70.
-
2005: Maurage C A; Udd B; Ruchoux M M; Vermersch P; Kalimo H; Krahe R; Delacourte A; Sergeant N
Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease.
Neurology 2005;65(10):1636-8.
-
2005: Vingtdeux Valérie; Hamdane Malika; Gompel Marie; Bégard Séverine; Drobecq Hervé; Ghestem Antoine; Grosjean Marie-Eve; Kostanjevecki Vesna; Grognet Pierre; Vanmechelen Eugeen; Buée Luc; Delacourte André; Sergeant Nicolas
Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.
Neurobiology of disease 2005;20(2):625-37.
-
2005: Santiard-Baron Dominique; Langui Dominique; Delehedde Maryse; Delatour Benoît; Schombert Brigitte; Touchet Nathalie; Tremp Günter; Paul Marie-Françoise; Blanchard Véronique; Sergeant Nicolas; Delacourte André; Duyckaerts Charles; Pradier Laurent; Mercken Luc
Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load.
Journal of neurochemistry 2005;93(2):330-8.
-
2005: Hamdane Malika; Bretteville Alexis; Sambo Anne-Véronique; Schindowski Katharina; Bégard Séverine; Delacourte André; Bertrand Philippe; Buée Luc
p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death.
Journal of cell science 2005;118(Pt 6):1291-8.
-
2005: Lain Enzo; Penke Botond; Delacourte André; Gündisch Daniela; Schröder Hannsjörg; Witter Brigitte
Effects of Abeta1-42 fibrils and of the tetrapeptide Pr-IIGL on the phosphorylation state of the tau-protein and on the alpha7 nicotinic acetylcholine receptor in vitro.
The European journal of neuroscience 2005;21(4):879-88.
-
2005: Delobel P; Leroy O; Hamdane M; Sambo A V; Delacourte A; Buée L
Proteasome inhibition and Tau proteolysis: an unexpected regulation.
FEBS letters 2005;579(1):1-5.
-
2005: Sergeant Nicolas; Delacourte André; Buée Luc
Tau protein as a differential biomarker of tauopathies.
Biochimica et biophysica acta 2005;1739(2-3):179-97.
-
2005: Delacourte Andre
Tauopathies: recent insights into old diseases.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2005;43(4):244-57.
-
2004: Abad-Rodriguez Jose; Ledesma Maria Dolores; Craessaerts Katleen; Perga Simona; Medina Miguel; Delacourte Andre; Dingwall Colin; De Strooper Bart; Dotti Carlos G
Neuronal membrane cholesterol loss enhances amyloid peptide generation.
The Journal of cell biology 2004;167(5):953-60.
-
2004: Maurage C-A; Bussière T; Sergeant N; Ghesteem A; Figarella-Branger D; Ruchoux M-M; Pellissier J-F; Delacourte A
Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies.
Neuropathology and applied neurobiology 2004;30(6):624-34.
-
2004: Funalot B; Ouimet T; Claperon A; Fallet C; Delacourte A; Epelbaum J; Subkowski T; Léonard N; Codron V; David J-P; Amouyel P; Schwartz J-C; Helbecque N
Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease.
Molecular psychiatry 2004;9(12):1122-8, 1059.
-
2004: Casas Caty; Sergeant Nicolas; Itier Jean-Michel; Blanchard Véronique; Wirths Oliver; van der Kolk Nicolien; Vingtdeux Valérie; van de Steeg Evita; Ret Gwenaëlle; Canton Thierry; Drobecq Hervé; Clark Allan; Bonici Bruno; Delacourte André; Benavides Jesús; Schmitz Christoph; Tremp Günter; Bayer Thomas A; Benoit Patrick; Pradier Laurent
Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.
The American journal of pathology 2004;165(4):1289-300.
-
2004: Sibon Igor; Macia Frédéric; Vital Anne; Delacourte André; Tison François
Hypertension and progressive supranuclear palsy: is everything so clear?
Movement disorders : official journal of the Movement Disorder Society 2004;19(10):1259-61.
-
2004: Guevara J; Dilhuydy H; Espinosa B; Delacourte A; Quirion R; Mena R; Joanette Y; Zenteno E; Robitaille Y
Coexistence of reactive plasticity and neurodegeneration in Alzheimer diseased brains.
Histology and histopathology 2004;19(4):1075-84.
-
2004: Dhaenens Claire-Marie; Van Brussel Edwige; Schraen-Maschke Susanna; Pasquier Florence; Delacourte André; Sablonnière Bernard
Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease.
Neuroscience letters 2004;368(3):290-2.
-
2004: Le Ber Isabelle; Martinez Maria; Campion Dominique; Laquerrière Annie; Bétard Christine; Bassez Guillaume; Girard Carol; Saugier-Veber Pascale; Raux Gregory; Sergeant Nicolas; Magnier Patrick; Maisonobe Thierry; Eymard Bruno; Duyckaerts Charles; Delacourte André; Frebourg Thierry; Hannequin Didier
A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
Brain : a journal of neurology 2004;127(Pt 9):1979-92.
-
2004: Borghi Roberta; Piccini Alessandra; Delacourte Andrè; Strocchi Paola; Zaccheo Damiano; Tabaton Massimo
Protein levels of glycogen synthase 3 kinase are normal in progressive supranuclear palsy.
Neuroscience letters 2004;366(1):67-70.
-
2004: Soulié Cathia; Nicole Annie; Delacourte André; Ceballos-Picot Irène
Examination of stress-related genes in human temporal versus occipital cortex in the course of neurodegeneration: involvement of 14-3-3 zeta in this dynamic process.
Neuroscience letters 2004;365(1):1-5.
-
2004: Schraen-Maschke Susanna; Dhaenens Claire-Marie; Delacourte André; Sablonnière Bernard
Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.
Neurobiology of disease 2004;15(3):449-60.
-
2003: Delobel Patrice; Mailliot Christel; Hamdane Malika; Sambo Anne-Véronique; Bégard Séverine; Violleau Anne; Delacourte André; Buée Luc
Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies.
Annals of the New York Academy of Sciences 2003;1010():623-34.
-
2003: Ledesma Maria Dolores; Abad-Rodriguez José; Galvan Cristian; Biondi Elisa; Navarro Pilar; Delacourte Andre; Dingwall Colin; Dotti Carlos G
Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains.
EMBO reports 2003;4(12):1190-6.
-
2003: Maurage Claude-Alain; Sergeant Nicolas; Schraen-Maschke Susanna; Lebert Florence; Ruchoux Marie-Magdeleine; Sablonnière Bernard; Pasquier Florence; Delacourte André
Diffuse form of argyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain disease.
Acta neuropathologica 2003;106(6):575-83.
-
2003: Delacourte André; Sergeant Nicolas; Buée Luc
In vitro models of age-related neurodegenerative disorders.
Experimental gerontology 2003;38(11-12):1309-17.
-
2003: Hamdane Malika; Delobel Patrice; Sambo Anne-Véronique; Smet Caroline; Bégard Séverine; Violleau Anne; Landrieu Isabelle; Delacourte André; Lippens Guy; Flament Stéphane; Buée Luc
Neurofibrillary degeneration of the Alzheimer-type: an alternate pathway to neuronal apoptosis?
Biochemical pharmacology 2003;66(8):1619-25.
-
2003: Hamdane Malika; Sambo Anne-Véronique; Delobel Patrice; Bégard Séverine; Violleau Anne; Delacourte André; Bertrand Philippe; Benavides Jesus; Buée Luc
Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex.
The Journal of biological chemistry 2003;278(36):34026-34.
-
2003: Sergeant Nicolas; Bombois Stepanie; Ghestem Antoine; Drobecq Hervé; Kostanjevecki Vesna; Missiaen Carla; Wattez Annick; David Jean-Phillipe; Vanmechelen Eugeen; Sergheraert Christian; Delacourte André
Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach.
Journal of neurochemistry 2003;85(6):1581-91.
-
2003: Lesné Sylvain; Docagne Fabian; Gabriel Cecilia; Liot Géraldine; Lahiri Debomoy K; Buée Luc; Plawinski Laurent; Delacourte André; MacKenzie Eric T; Buisson Alain; Vivien Denis
Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice.
The Journal of biological chemistry 2003;278(20):18408-18.
-
2003: Weill-Engerer Sébastien; David Jean Philippe; Sazdovitch Véronique; Liere Philippe; Schumacher Michael; Delacourte André; Baulieu Etienne Emile; Akwa Yvette
In vitro metabolism of dehydroepiandrosterone (DHEA) to 7alpha-hydroxy-DHEA and Delta5-androstene-3beta,17beta-diol in specific regions of the aging brain from Alzheimer's and non-demented patients.
Brain research 2003;969(1-2):117-25.
-
2003: Maurage Claude-Alain; Sergeant Nicolas; Ruchoux Marie-Magdeleine; Hauw Jean-Jacques; Delacourte André
Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology.
Acta neuropathologica 2003;105(2):89-97.
-
2003: Royall Donald R; Román Gustavo C; Delacourte André
Pathological determinants of dementia in Alzheimer's disease (AD).
Experimental aging research 2003;29(1):107-10.
-
2003: Lefebvre Tony; Ferreira Stéphanie; Dupont-Wallois Laetitia; Bussière Thierry; Dupire Marie-Joëlle; Delacourte André; Michalski Jean-Claude; Caillet-Boudin Marie-Laure
Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization.
Biochimica et biophysica acta 2003;1619(2):167-76.
-
2003: Lefebvre Tony; Caillet-Boudin Marie-Laure; Buée Luc; Delacourte André; Michalski Jean-Claude
O-GlcNAc glycosylation and neurological disorders.
Advances in experimental medicine and biology 2003;535():189-202.
-
2003: Winsky-Sommerer R; Grouselle D; Rougeot C; Laurent V; David J-P; Delacourte A; Dournaud P; Seidah N G; Lindberg I; Trottier S; Epelbaum J
The proprotein convertase PC2 is involved in the maturation of prosomatostatin to somatostatin-14 but not in the somatostatin deficit in Alzheimer's disease.
Neuroscience 2003;122(2):437-47.
-
2003: Munoz David G; Dickson Dennis W; Bergeron Catherine; Mackenzie Ian R A; Delacourte Andre; Zhukareva Victoria
The neuropathology and biochemistry of frontotemporal dementia.
Annals of neurology 2003;54 Suppl 5():S24-8.
-
2003: Sergeant N; Wattez A; Galván-valencia M; Ghestem A; David J-P; Lemoine J; Sautiére P-E; Dachary J; Mazat J-P; Michalski J-C; Velours J; Mena-López R; Delacourte A
Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease.
Neuroscience 2003;117(2):293-303.
-
2002: Hamdane Malika; Smet Caroline; Sambo Anne-Véronique; Leroy Arnaud; Wieruszeski Jean-Michel; Delobel Patrice; Maurage Claude-Alain; Ghestem Antoine; Wintjens René; Bégard Séverine; Sergeant Nicolas; Delacourte André; Horvath Dragos; Landrieu Isabelle; Lippens Guy; Buée Luc
Pin1: a therapeutic target in Alzheimer neurodegeneration.
Journal of molecular neuroscience : MN 2002;19(3):275-87.
-
2002: Weill-Engerer Sébastien; David Jean-Philippe; Sazdovitch Véronique; Liere Philippe; Eychenne Bernard; Pianos Antoine; Schumacher Michael; Delacourte André; Baulieu Etienne-Emile; Akwa Yvette
Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients.
The Journal of clinical endocrinology and metabolism 2002;87(11):5138-43.
-
2002: Delacourte André; Sergeant Nicolas; Wattez Annick; Maurage Claude-Alain; Lebert Florence; Pasquier Florence; David Jean-Philippe
Tau aggregation in the hippocampal formation: an ageing or a pathological process?
Experimental gerontology 2002;37(10-11):1291-6.
-
2002: Delobel Patrice; Flament Stéphane; Hamdane Malika; Mailliot Christel; Sambo Anne-Véronique; Bégard Séverine; Sergeant Nicolas; Delacourte André; Vilain Jean-Pierre; Buée Luc
Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis.
Journal of neurochemistry 2002;83(2):412-20.
-
2002: Tolnay Markus; Sergeant Nicolas; Ghestem Antoine; Chalbot Sonia; De Vos Rob A I; Jansen Steur Ernst N H; Probst Alphonse; Delacourte André
Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms.
Acta neuropathologica 2002;104(4):425-34.
-
2002: Delacourte A; Sergeant N; Champain D; Wattez A; Maurage C-A; Lebert F; Pasquier F; David J-P
Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease.
Neurology 2002;59(3):398-407.
-
2002: Sergeant Nicolas; David Jean-Philippe; Champain Danie; Ghestem Antoine; Wattez Annick; Delacourte André
Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease.
Journal of neurochemistry 2002;81(4):663-72.
-
2002: Delobel P; Flament S; Hamdane M; Delacourte A; Vilain J P; Buée L
Modelling Alzheimer-specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities.
FEBS letters 2002;516(1-3):151-5.
-
2002: Royall Donald R; Palmer Raymond; Mulroy Amy R; Polk Marsha J; Román Gustavo C; David Jean-Phillippe; Delacourte André
Pathological determinants of the transition to clinical dementia in Alzheimer's disease.
Experimental aging research 2002;28(2):143-62.
-
2002: Caparros-Lefebvre Dominique; Sergeant Nicolas; Lees Andrew; Camuzat Agnes; Daniel Susan; Lannuzel Annie; Brice Alexis; Tolosa Eduardo; Delacourte Andre; Duyckaerts Charles
Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Brain : a journal of neurology 2002;125(Pt 4):801-11.
-
2002: Delobel Patrice; Flament Stéphane; Hamdane Malika; Jakes Ross; Rousseau Arlette; Delacourte André; Vilain Jean-Pierre; Goedert Michel; Buée Luc
Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation.
The Journal of biological chemistry 2002;277(11):9199-205.
-
2002: Borghi R; Giliberto L; Assini A; Delacourte A; Perry G; Smith M A; Strocchi P; Zaccheo D; Tabaton M
Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
Neurology 2002;58(4):589-92.
-
2002: Bons Noëlle; Lehmann Sylvain; Nishida Noriyuki; Mestre-Frances Nadine; Dormont Dominique; Belli Patrick; Delacourte Andre; Grassi Jacques; Brown Paul
BSE infection of the small short-lived primate Microcebus murinus.
Comptes rendus biologies 2002;325(1):67-74.
-
2002: Buée Luc; Hamdane Malika; Delobel Patrice; Sambo Anne-Véronique; Bégard Séverine; Ghestem Antoine; Sergeant Nicolas; Delacourte André
[Tau story: from frontotemporal dementia to other tauopathies]
Journal de la Société de biologie 2002;196(1):103-8.
-
2001: Seznec H; Agbulut O; Sergeant N; Savouret C; Ghestem A; Tabti N; Willer J C; Ourth L; Duros C; Brisson E; Fouquet C; Butler-Browne G; Delacourte A; Junien C; Gourdon G
Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.
Human molecular genetics 2001;10(23):2717-26.
-
2001: Maurage C A; Sergeant N; Ruchoux M M; Hauw J J; Delacourte A
Paradoxical phosphorylation of the serine 199 on tau proteins from young individuals.
Neuroreport 2001;12(15):3177-81.
-
2001: Sergeant N; Sablonnière B; Schraen-Maschke S; Ghestem A; Maurage C A; Wattez A; Vermersch P; Delacourte A
Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1.
Human molecular genetics 2001;10(19):2143-55.
-
2001: Riederer B M; Mourton-Gilles C; Frey P; Delacourte A; Probst A
Differential phosphorylation of tau proteins during kitten brain development and Alzheimer's disease.
Journal of neurocytology 2001;30(2):145-58.
-
2001: Guise S; Braguer D; Carles G; Delacourte A; Briand C
Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells.
Journal of neuroscience research 2001;63(3):257-67.
-
2001: Buée L; Delacourte A; Wilhelmsen K C; Miller B; Geschwind D
Neuronal subpopulations and genetic background in tauopathies: a catch 22 story?
Neurobiology of aging 2001;22(1):115-21.
-
2001: Delacourte A
The molecular parameters of tau pathology. Tau as a killer and a witness.
Advances in experimental medicine and biology 2001;487():5-19.
-
2000: Ledesma M D; Da Silva J S; Crassaerts K; Delacourte A; De Strooper B; Dotti C G
Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains.
EMBO reports 2000;1(6):530-5.
-
2000: Ferreira S; Dupire M J; Delacourte A; Najib J; Caillet-Boudin M L
Synthesis and regulation of apolipoprotein E during the differentiation of human neuronal precursor NT2/D1 cells into postmitotic neurons.
Experimental neurology 2000;166(2):415-21.
-
2000: Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen S H; Dickson D W
A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
Acta neuropathologica 2000;100(3):235-44.
-
2000: Delacourte A; Buée L
Tau pathology: a marker of neurodegenerative disorders.
Current opinion in neurology 2000;13(4):371-6.
-
2000: Buée L; Bussière T; Buée-Scherrer V; Delacourte A; Hof P R
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.
Brain research. Brain research reviews 2000;33(1):95-130.
-
2000: Delacourte A
[Natural and molecular history of Alzheimer disease]
Annales de biologie clinique 2000;58(3):350-5.
-
2000: Litvan I; Dickson D W; Buttner-Ennever J A; Delacourte A; Hutton M; Dubois B; Golbe L I; Hallett M; Schellenberg G D; Standaert D; Brooks D J; Price D
Research goals in progressive supranuclear palsy. First International Brainstorming Conference on PSP.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):446-58.
-
2000: Mailliot C; Podevin-Dimster V; Rosenthal R E; Sergeant N; Delacourte A; Fiskum G; Buée L
Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2000;20(3):543-9.
-
2000: Mailliot C; Bussière T; Hamdane M; Sergeant N; Caillet M L; Delacourte A; Buée L
Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities.
Annals of the New York Academy of Sciences 2000;920():107-14.
-
1999: Buée L; Delacourte A
Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease.
Brain pathology (Zurich, Switzerland) 1999;9(4):681-93.
-
1999: Pérez-Tur J; Buée L; Morris H R; Waring S C; Onstead L; Wavrant-De Vrièze F; Crook R; Buée-Scherrer V; Hof P R; Petersen R C; McGeer P L; Delacourte A; Hutton M; Siddique T; Ahlskog J E; Hardy J; Steele J C
Neurodegenerative diseases of Guam: analysis of TAU.
Neurology 1999;53(2):411-3.
-
1999: Sato N; Hori O; Yamaguchi A; Lambert J C; Chartier-Harlin M C; Robinson P A; Delacourte A; Schmidt A M; Furuyama T; Imaizumi K; Tohyama M; Takagi T
A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue.
Journal of neurochemistry 1999;72(6):2498-505.
-
1999: Soulié C; Mitchell V; Dupont-Wallois L; Chartier-Harlin M C; Beauvillain J C; Delacourte A; Caillet-Boudin M L
Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE.
Neuroscience letters 1999;265(2):147-50.
-
1999: Delacourte A; David J P; Sergeant N; Buée L; Wattez A; Vermersch P; Ghozali F; Fallet-Bianco C; Pasquier F; Lebert F; Petit H; Di Menza C
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
Neurology 1999;52(6):1158-65.
-
1999: Bussière T; Hof P R; Mailliot C; Brown C D; Caillet-Boudin M L; Perl D P; Buée L; Delacourte A
Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration.
Acta neuropathologica 1999;97(3):221-30.
-
1999: Sergeant N; Wattez A; Delacourte A
Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms.
Journal of neurochemistry 1999;72(3):1243-9.
-
1999: Brique S; Destée A; Lambert J C; Mouroux V; Delacourte A; Amouyel P; Chartier-Harlin M C
A new GTP-cyclohydrolase I mutation in an unusual dopa-responsive dystonia, familial form.
Neuroreport 1999;10(3):487-91.
-
1999: Delacourte A
Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias.
Dementia and geriatric cognitive disorders 1999;10 Suppl 1():75-9.
-
1998: Pasquier F; Delacourte A
Non-Alzheimer degenerative dementias.
Current opinion in neurology 1998;11(5):417-27.
-
1998: Grouselle D; Winsky-Sommerer R; David J P; Delacourte A; Dournaud P; Epelbaum J
Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele.
Neuroscience letters 1998;255(1):21-4.
-
1998: Mailliot C; Bussière T; Caillet-Boudin M L; Delacourte A; Buée L
Alzheimer-specific epitope of AT100 in transfected cell lines with tau: toward an efficient cell model of tau abnormal phosphorylation.
Neuroscience letters 1998;255(1):13-6.
-
1998: Lambert J C; Berr C; Pasquier F; Delacourte A; Frigard B; Cottel D; Pérez-Tur J; Mouroux V; Mohr M; Cécyre D; Galasko D; Lendon C; Poirier J; Hardy J; Mann D; Amouyel P; Chartier-Harlin M C
Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.
Human molecular genetics 1998;7(9):1511-6.
-
1998: Mailliot C; Sergeant N; Bussière T; Caillet-Boudin M L; Delacourte A; Buée L
Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.
FEBS letters 1998;433(3):201-4.
-
1998: Soyeux P; Delacourte A; Delie B; Lefevre P; Boniface B
Influence and optimisation of operating parameters with a new binder in wet granulation. I: use in powder form.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1998;46(1):95-103.
-
1998: Caillet-Boudin M L; Dupont-Wallois L; Soulié C; Delacourte A
Apolipoprotein E and Tau phosphorylation in human neuroblastoma cells.
Neuroscience letters 1998;250(2):83-6.
-
1998: Delacourte A
[Diagnosis of Alzheimer's disease]
Annales de biologie clinique 1998;56(2):133-42.
-
1998: Delacourte A; Sergeant N; Wattez A; Gauvreau D; Robitaille Y
Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation.
Annals of neurology 1998;43(2):193-204.
-
1997: Lambert J C; Pérez-Tur J; Dupire M J; Galasko D; Mann D; Amouyel P; Hardy J; Delacourte A; Chartier-Harlin M C
Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.
Human molecular genetics 1997;6(12):2151-4.
-
1997: David J P; Ghozali F; Fallet-Bianco C; Wattez A; Delaine S; Boniface B; Di Menza C; Delacourte A
Glial reaction in the hippocampal formation is highly correlated with aging in human brain.
Neuroscience letters 1997;235(1-2):53-6.
-
1997: Buée L; Hof P R; Delacourte A
Brain microvascular changes in Alzheimer's disease and other dementias.
Annals of the New York Academy of Sciences 1997;826():7-24.
-
1997: Buée-Scherrer V; Buée L; Leveugle B; Perl D P; Vermersch P; Hof P R; Delacourte A
Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders.
Annals of neurology 1997;42(3):356-9.
-
1997: Tranchant C; Sergeant N; Wattez A; Mohr M; Warter J M; Delacourte A
Neurofibrillary tangles in Gerstmann-Sträussler-Scheinker syndrome with the A117V prion gene mutation.
Journal of neurology, neurosurgery, and psychiatry 1997;63(2):240-6.
-
1997: Sergeant N; David J P; Lefranc D; Vermersch P; Wattez A; Delacourte A
Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases.
FEBS letters 1997;412(3):578-82.
-
1997: Sergeant N; David J P; Goedert M; Jakes R; Vermersch P; Buée L; Lefranc D; Wattez A; Delacourte A
Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications.
Journal of neurochemistry 1997;69(2):834-44.
-
1997: Wavrant-DeVrièze F; Pérez-Tur J; Lambert J C; Frigard B; Pasquier F; Delacourte A; Amouyel P; Hardy J; Chartier-Harlin M C
Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease.
Neuroscience letters 1997;227(1):68-70.
-
1997: Dupont-Wallois L; Soulié C; Sergeant N; Wavrant-de Wrieze N; Chartier-Harlin M C; Delacourte A; Caillet-Boudin M L
ApoE synthesis in human neuroblastoma cells.
Neurobiology of disease 1997;4(5):356-64.
-
1997: Delacourte A; Buée L
Normal and pathological Tau proteins as factors for microtubule assembly.
International review of cytology 1997;171():167-224.
-
1996: Caillet-Boudin M L; Delacourte A
Induction of a specific tau Alzheimer epitope in SY-5Y neuroblastoma cells.
Neuroreport 1996;8(1):307-10.
-
1996: Lambert J C; Pérez-Tur J; Dupire M J; Delacourte A; Frigard B; Chartier-Harlin M C
Analysis of the APOE alleles impact in Down's syndrome.
Neuroscience letters 1996;220(1):57-60.
-
1996: Vermersch P; Sergeant N; Ruchoux M M; Hofmann-Radvanyi H; Wattez A; Petit H; Dwailly P; Delacourte A
Specific tau variants in the brains of patients with myotonic dystrophy.
Neurology 1996;47(3):711-7.
-
1996: Lefranc D; Vermersch P; Dallongeville J; Daems-Monpeurt C; Petit H; Delacourte A
Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.
Neuroscience letters 1996;212(2):91-4.
-
1996: Buée-Scherrer V; Condamines O; Mourton-Gilles C; Jakes R; Goedert M; Pau B; Delacourte A
AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease.
Brain research. Molecular brain research 1996;39(1-2):79-88.
-
1996: Soulié C; Lépagnol J; Delacourte A; Caillet-Boudin M L
Dephosphorylation studies of SKNSH-SY 5Y cell Tau proteins by endogenous phosphatase activity.
Neuroscience letters 1996;206(2-3):189-92.
-
1996: Delacourte A; Robitaille Y; Sergeant N; Buée L; Hof P R; Wattez A; Laroche-Cholette A; Mathieu J; Chagnon P; Gauvreau D
Specific pathological Tau protein variants characterize Pick's disease.
Journal of neuropathology and experimental neurology 1996;55(2):159-68.
-
1996: Couratier P; Lesort M; Condamines O; Mourton-Gilles C; Delacourte A; Hugon J
Phorbol ester enhances phosphorylated tau protein immunoreactivity in neuronal cultures.
Neuroscience letters 1996;203(3):155-8.
-
1996: Buée Scherrer V; Hof P R; Buée L; Leveugle B; Vermersch P; Perl D P; Olanow C W; Delacourte A
Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease.
Acta neuropathologica 1996;91(4):351-9.
-
1996: Buée L; Pérez-Tur J; Leveugle B; Buée-Scherrer V; Mufson E J; Loerzel A J; Chartier-Harlin M C; Perl D P; Delacourte A; Hof P R
Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes.
Acta neuropathologica 1996;91(3):247-53.
-
1995: Pérez-Tur J; Campion D; Martinez M; Brice A; Tardieu S; Hannequin D; Agid Y; Delacourte A; Clerget-Darpoux F; Chartier-Harlin M C
Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives.
American journal of medical genetics 1995;60(6):550-3.
-
1995: Sergeant N; Bussière T; Vermersch P; Lejeune J P; Delacourte A
Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins.
Neuroreport 1995;6(16):2217-20.
-
1995: Vermersch P; David J P; Frigard B; Fallet-Bianco C; Wattez A; Petit H; Delacourte A
Cortical mapping of Alzheimer pathology in brains of aged non-demented subjects.
Progress in neuro-psychopharmacology & biological psychiatry 1995;19(6):1035-47.
-
1995: Buée L; Permanne B; Pérez-Tur J; Chartier-Harlin M C; Delacourte A
Alzheimer's disease: A beta or ApoE amyloidosis?
Lancet 1995;346(8966):59.
-
1995: Bons N; Jallageas V; Silhol S; Mestre-Frances N; Petter A; Delacourte A
Immunocytochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1995;318(7):741-7.
-
1995: Permanne B; Buée L; David J P; Fallet-Bianco C; Di Menza C; Delacourte A
Quantitation of Alzheimer's amyloid peptide and identification of related amyloid proteins by dot-blot immunoassay.
Brain research 1995;685(1-2):154-62.
-
1995: Condamines O; Buée-Scherrer V; Boissier L; Wattez A; Delacourte A; Pau B; Mourton-Gilles C
New immunoassay for the mapping of neurofibrillary degeneration in Alzheimer's disease using two monoclonal antibodies against human paired helical filament tau proteins.
Neuroscience letters 1995;192(2):81-4.
-
1995: Buée-Scherrer V; Buée L; Hof P R; Leveugle B; Gilles C; Loerzel A J; Perl D P; Delacourte A
Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.
The American journal of pathology 1995;146(4):924-32.
-
1995: Vermersch P; Bordet R; Ledoze F; Ruchoux M M; Chapon F; Thomas P; Destée A; Lechevallier B; Delacourte A
[Demonstration of a specific profile of pathological Tau proteins in frontotemporal dementia cases]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1995;318(4):439-45.
-
1995: Dupont-Wallois L; Sautière P E; Cocquerelle C; Bailleul B; Delacourte A; Caillet-Boudin M L
Shift from fetal-type to Alzheimer-type phosphorylated Tau proteins in SKNSH-SY 5Y cells treated with okadaic acid.
FEBS letters 1995;357(2):197-201.
-
1995: Delacourte A; Sautière P E; Wattez A; Mourton-Gilles C; Petter A; Bons N
Biochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1995;318(1):85-9.
-
1995: Bons N; Jallageas V; Silhol S; Mestre-Frances N; Petter A; Delacourte A
Immunocytochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1995;318(1):77-83.
-
1995: Reig S; Buée-Scherrer V; Mourton-Gilles C; Defossez A; Delacourte A; Beauvillain J C; Mazzuca M
Immunogold labelling of paired helical filaments and amyloid fibrils by specific monoclonal and polyclonal antibodies.
Acta neuropathologica 1995;90(5):441-7.
-
1994: Giannakopoulos P; Hof P R; Giannakopoulos A S; Buée-Scherrer V; Surini M; Delacourte A; Bouras C
Dementia in the oldest-old: quantitative analysis of 12 cases from a psychiatric hospital.
Dementia (Basel, Switzerland) 1994;5(6):348-56.
-
1994: Vickers J C; Riederer B M; Marugg R A; Buée-Scherrer V; Buée L; Delacourte A; Morrison J H
Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease.
Neuroscience 1994;62(1):1-13.
-
1994: David J P; Fallet-Bianco C; Vermersch P; Frigard B; Di Menza C; Delacourte A
[Normal cerebral aging: study of glial reaction]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1994;317(8):749-53.
-
1994: Vermersch P; Robitaille Y; Bernier L; Wattez A; Gauvreau D; Delacourte A
Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement.
Acta neuropathologica 1994;87(6):572-7.
-
1994: Buée L; Hof P R; Bouras C; Delacourte A; Perl D P; Morrison J H; Fillit H M
Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.
Acta neuropathologica 1994;87(5):469-80.
-
1994: Vermersch P; Daems-Monpeurt C; Parent M; Pruvo J P; Delacourte A; Petit H
[Subcortical dementia of the Neumann type. Contribution of diagnostic imaging]
Revue neurologique 1994;150(5):354-8.
-
1994: Delacourte A
Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1994;48(7):287-95.
-
1994: Hof P R; Nimchinsky E A; Buée-Scherrer V; Buée L; Nasrallah J; Hottinger A F; Purohit D P; Loerzel A J; Steele J C; Delacourte A
Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders.
Acta neuropathologica 1994;88(5):397-404.
-
1993: Buée L; Ding W; Anderson J P; Narindrasorasak S; Kisilevsky R; Boyle N J; Robakis N K; Delacourte A; Greenberg B; Fillit H M
Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.
Brain research 1993;627(2):199-204.
-
1993: Vermersch P; Delacourte A; Javoy-Agid F; Hauw J J; Agid Y
Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins.
Annals of neurology 1993;33(5):445-50.
-
1993: Delacourte A
[Physiopathological bases of Alzheimer disease]
Thérapie 1993;48(3):177-83.
-
1993: Vermersch P; Sautière P E; Goudemand M; Delacourte A
General cortical involvement in a late-onset case of Alzheimer disease. A biochemical approach by quantitation of abnormal tau proteins.
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1993;18(3):213-24.
-
1993: Carette B; Poulain P; Delacourte A
Electrophysiological effects of 25-35 amyloid-beta-protein on guinea-pig lateral septal neurons.
Neuroscience letters 1993;151(1):111-4.
-
1993: Buée L; Ding W; Delacourte A; Fillit H
Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.
Brain research 1993;601(1-2):154-63.
-
1993: Sindou P; Sautiere P E; Couratier P; Delacourte A; Hugon J
[Antigenic changes of Tau protein induced by glutamate on primary cultures of neurons: immunocytochemistry study]
Comptes rendus des séances de la Société de biologie et de ses filiales 1993;187(1):87-95.
-
1993: Sautière P E; Caillet-Boudin M L; Wattez A; Buée-Scherrer V; Delacourte A
[Detection of Alzheimer type pathological epitopes on Tau proteins of neuroblastoma cells after treatment with okadaic acid]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(5):533-5.
-
1992: Vickers J C; Delacourte A; Morrison J H
Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease.
Brain research 1992;594(2):273-8.
-
1992: Buée L; Hof P R; Roberts D D; Delacourte A; Morrison J H; Fillit H M
Immunohistochemical identification of thrombospondin in normal human brain and in Alzheimer's disease.
The American journal of pathology 1992;141(4):783-8.
-
1992: Hof P R; Bierer L M; Perl D P; Delacourte A; Buée L; Bouras C; Morrison J H
Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques.
Archives of neurology 1992;49(9):946-53.
-
1992: Vermersch P; Frigard B; David J P; Fallet-Bianco C; Delacourte A
Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjects.
Neuroscience letters 1992;144(1-2):143-6.
-
1992: Sautière P E; Sindou P; Couratier P; Hugon J; Wattez A; Delacourte A
Tau antigenic changes induced by glutamate in rat primary culture model: a biochemical approach.
Neuroscience letters 1992;140(2):206-10.
-
1992: Hof P R; Charpiot A; Delacourte A; Buée L; Purohit D; Perl D P; Bouras C
Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism.
Neuroscience letters 1992;139(1):10-4.
-
1992: Crawford F; Chartier-Harlin M C; Mullan M; Hardy J; Delacourte A; Arnott G
Alzheimer's--a correction.
Nature 1992;356(6368):390.
-
1992: Lucas C; Parent M; Delandsheer E; Delacourte A; Fournier Y; Défossez A; Leys D
[Multiple cerebral hemorrhage and amyloid angiopathy of the white matter in a case of Alzheimer's disease]
Revue neurologique 1992;148(3):218-20.
-
1992: Hof P R; Delacourte A; Bouras C
Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases.
Acta neuropathologica 1992;84(1):45-51.
-
1992: Vallet P G; Guntern R; Hof P R; Golaz J; Delacourte A; Robakis N K; Bouras C
A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease.
Acta neuropathologica 1992;83(2):170-8.
-
1992: Vermersch P; Frigard B; Delacourte A
Mapping of neurofibrillary degeneration in Alzheimer's disease: evaluation of heterogeneity using the quantification of abnormal tau proteins.
Acta neuropathologica 1992;85(1):48-54.
-
1992: Hof P R; Bouras C; Buée L; Delacourte A; Perl D P; Morrison J H
Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases.
Acta neuropathologica 1992;85(1):23-30.
-
1991: Behrouz N; Defossez A; Delacourte A; Mazzuca M
The immunohistochemical evidence of amyloid diffuse deposits as a pathological hallmark in Alzheimer's disease.
Journal of gerontology 1991;46(6):B209-12.
-
1991: Defossez A; Delacourte A; Mazzuca M
[Brain lesions in Alzheimer's disease: contribution of ultrastructural observations]
Bulletin de l'Association des anatomistes 1991;75(229):89-92.
-
1991: Buee L; Boyle N J; Zhang L B; Delacourte A; Fillit H M
Optimization of an alcian blue dot-blot assay for the detection of glycosaminoglycans and proteoglycans.
Analytical biochemistry 1991;195(2):238-42.
-
1991: Ceballos-Picot I; Nicole A; Briand P; Grimber G; Delacourte A; Defossez A; Javoy-Agid F; Lafon M; Blouin J L; Sinet P M
Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome.
Brain research 1991;552(2):198-214.
-
1991: Furby A; Leys D; Delacourte A; Buee L; Soetaert G; Petit H
Are alpha-1-antichymotrypsin and inter-alpha-trypsin inhibitor peripheral markers of Alzheimer's disease?
Journal of neurology, neurosurgery, and psychiatry 1991;54(5):469.
-
1991: Leys D; Pruvo J P; Parent M; Vermersch P; Soetaert G; Steinling M; Delacourte A; Défossez A; Rapoport A; Clarisse J
Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder?
Journal of neurology, neurosurgery, and psychiatry 1991;54(1):46-50.
-
1991: Ceballos I; Javoy-Agid F; Delacourte A; Defossez A; Lafon M; Hirsch E; Nicole A; Sinet P M; Agid Y
Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains.
Free radical research communications 1991;12-13 Pt 2():571-80.
-
1991: Flament S; Delacourte A; Verny M; Hauw J J; Javoy-Agid F
Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.
Acta neuropathologica 1991;81(6):591-6.
-
1991: Ceballos I; Nicole A; Briand P; Grimber G; Delacourte A; Flament S; Blouin J L; Thevenin M; Kamoun P; Sinet P M
Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome.
Free radical research communications 1991;12-13 Pt 2():581-9.
-
1990: Flament S; Delacourte A
Tau marker?
Nature 1990;346(6279):22.
-
1990: Flament S; Delacourte A; Mann D M
Phosphorylation of Tau proteins: a major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome.
Brain research 1990;516(1):15-9.
-
1990: Behrouz N; Defossez A; Delacourte A; Mazzuca M
Cortical beta-amyloid.
Nature 1990;344(6266):497.
-
1990: Delacourte A; Flament S; Defossez A
[Towards the development of an in vivo study model of Alzheimer-type neurofibrillary degeneration]
Presse médicale (Paris, France : 1983) 1990;19(4):170-3.
-
1990: Delacourte A
General and dramatic glial reaction in Alzheimer brains.
Neurology 1990;40(1):33-7.
-
1990: Ceballos I; Javoy-Agid F; Delacourte A; Defossez A; Nicole A; Sinet P M
Parkinson's disease and Alzheimer's disease: neurodegenerative disorders due to brain antioxidant system deficiency?
Advances in experimental medicine and biology 1990;264():493-8.
-
1990: Delacourte A
[Experimental approach to neuronal degeneration]
Comptes rendus des séances de la Société de biologie et de ses filiales 1990;184(1):5-17.
-
1990: Flament S; Delacourte A; Delaère P; Duyckaerts C; Hauw J J
Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration.
Acta neuropathologica 1990;80(2):212-5.
-
1990: Delacourte A; Flament S; Dibe E M; Hublau P; Sablonnière B; Hémon B; Shérrer V; Défossez A
Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins.
Acta neuropathologica 1990;80(2):111-7.
-
1990: Behrouz N; Defossez A; Delacourte A; Mazzuca M
[Alzheimer's disease: the beta amyloid protein A4 is also present in the cortical white matter]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1990;310(11):539-44.
-
1989: Behrouz N; Defossez A; Delacourte A; Hublau P; Mazzuca M
An antiserum to the N-terminal subsequence of the Alzheimer amyloid beta protein does not react with neurofibrillary tangles.
Journal of gerontology 1989;44(6):B156-9.
-
1989: Buee L; Laine A; Delacourte A; Flament S; Han K K
Qualitative and quantitative comparison of brain proteins in Alzheimer's disease.
Biological chemistry Hoppe-Seyler 1989;370(11):1229-34.
-
1989: Behrouz N; Defossez A; Delacourte A; Hublau P; Mazzuca M
Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance.
Laboratory investigation; a journal of technical methods and pathology 1989;61(5):576-83.
-
1989: Mann D M; Prinja D; Davies C A; Ihara Y; Delacourte A; Défossez A; Mayer R J; Landon M
Immunocytochemical profile of neurofibrillary tangles in Down's syndrome patients of different ages.
Journal of the neurological sciences 1989;92(2-3):247-60.
-
1989: Flament S; Delacourte A; Hémon B; Défossez A
Characterization of two pathological tau protein, variants in Alzheimer brain cortices.
Journal of the neurological sciences 1989;92(2-3):133-41.
-
1989: Rosemblatt M; Fellous A; Mazie J C; Delacourte A; Defossez A
Alzheimer's disease: microtubule-associated proteins 2 (MAP 2) are not components of paired helical filaments.
FEBS letters 1989;252(1-2):91-4.
-
1989: Lenders M B; Peers M C; Tramu G; Delacourte A; Defossez A; Petit H; Mazzuca M
Dystrophic neuropeptidergic neurites in senile plaques of Alzheimer's disease precede formation of paired helical filaments.
Acta neurologica Belgica 1989;89(3-4):279-85.
-
1989: Delacourte A; Flament S; Behrouz N; Defossez A
[Alzheimer's disease: tau microtubular protein and beta protein A4 constitute 2 different types of amyloid substance]
Acta neurologica Belgica 1989;89(3-4):274-5.
-
1989: Flament S; Delacourte A
Abnormal tau species are produced during Alzheimer's disease neurodegenerating process.
FEBS letters 1989;247(2):213-6.
-
1989: Lenders M B; Peers M C; Tramu G; Delacourte A; Defossez A; Petit H; Mazzuca M
Dystrophic peptidergic neurites in senile plaques of Alzheimer's disease hippocampus precede formation of paired helical filaments.
Brain research 1989;481(2):344-9.
-
1989: Behrouz N; Defossez A; Delacourte A; Hublau P; Mazzuca M
[Alzheimer's disease: immunohistochemical characterization of cerebral amyloid deposits]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1989;308(16):437-44.
-
1989: Delacourte A; Buée L
[Alzheimer's disease: the glial reaction is general and severe in all areas of the central nervous system]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1989;308(13):359-65.
-
1989: Flament S; Delacourte A; Hemon B; Defossez A
[Direct demonstration of abnormal phosphorylation of Tau microtubular proteins in Alzheimer's disease]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1989;308(3):77-82.
-
1988: Delacourte A; Defossez A; Ceballos I; Nicole A; Sinet P M
Preferential localization of copper zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer's disease.
Neuroscience letters 1988;92(3):247-53.
-
1988: Amouyel P; Gégonne A; Delacourte A; Défossez A; Stéhelin D
Expression of ETS proto-oncogenes in astrocytes in human cortex.
Brain research 1988;447(1):149-53.
-
1988: Peers M C; Lenders M B; Défossez A; Delacourte A; Mazzuca M
Cortical angiopathy in Alzheimer's disease: the formation of dystrophic perivascular neurites is related to the exudation of amyloid fibrils from the pathological vessels.
Virchows Archiv. A, Pathological anatomy and histopathology 1988;414(1):15-20.
-
1988: Parent M; Delacourte A; Défossez A; Hémon B; Han K K; Petit H
[Alzheimer's disease: study of the distribution of tau proteins constituting helical filament pairs in human central nervous tissue]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1988;306(13):391-7.
-
1988: Defossez A; Beauvillain J C; Delacourte A; Mazzuca M
Alzheimer's disease: a new evidence for common epitopes between microtubule associated protein Tau and paired helical filaments (PHF): demonstration at the electron microscope level by a double immunogold labelling.
Virchows Archiv. A, Pathological anatomy and histopathology 1988;413(2):141-5.
-
1987: Défossez A; Delacourte A
Transformation of degenerating neurofibrils into amyloid substance in Alzheimer's disease: histochemical and immunohistochemical studies.
Journal of the neurological sciences 1987;81(1):1-10.
-
1987: Han K K; Delacourte A; Hemon B
Chemical modification of thiol group(s) in protein: application to the study of anti-microtubular drugs binding.
Comparative biochemistry and physiology. B, Comparative biochemistry 1987;88(4):1057-65.
-
1987: Defossez A; el Hachimi K; Beauvillain J C; Perre J; Delacourte A; Foncin J F
[Immunocytochemical study at the ultrastructural level of neurofibrillary degeneration in Alzheimer's disease]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1987;304(9):217-22.
-
1987: Delacourte A; Defossez A; Persuy P; Peers M C
Observation of morphological relationships between angiopathic blood vessels and degenerative neurites in Alzheimer's disease.
Virchows Archiv. A, Pathological anatomy and histopathology 1987;411(3):199-204.
-
1986: Delacourte A; Defossez A
Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments.
Journal of the neurological sciences 1986;76(2-3):173-86.
-
1986: Defossez A; Persuy P; Tramu G; Delacourte A
[Immunohistochemical study of the basic lesions of Alzheimer's disease]
L'Encéphale 1986;12(4):161-8.
-
1986: Mahboub S; Richard C; Delacourte A; Han K K
Applications of chemical cleavage procedures to the peptide mapping of neurofilament triplet protein bands in sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Analytical biochemistry 1986;154(1):171-82.
-
1986: Lesieur I; Lesieur D; Lespagnol C; Cazin M; Brunet C; Luyckx M; Mallevais M L; Delacourte A; Dubreuil L; Devos J
Chemical and pharmacological studies of 2-(amino-methyl)acrylophenones.
Arzneimittel-Forschung 1986;36(1):20-4.
-
1986: Mahboub S; Hemon B; Defossez A; Delacourte A; Han K K
Biochemical and immunological studies of bovine and porcine neurofilament triplet proteins by peptide mapping after cyanogen bromide cleavage.
Comparative biochemistry and physiology. B, Comparative biochemistry 1986;85(2):299-306.
-
1986: Delacourte A; Défossez A
[Biochemical characterization of an immune serum which specifically marks neurons in neurofibrillary degeneration in Alzheimer's disease]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1986;303(11):439-44.
-
1985: Bard J M; Luyckx M; Brunet C; Cazin M; Fruchart J C; Clavey V; Lesieur I; Lesieur D; Delacourte A
Normolipemic activities of acrylophenone derivatives with antimicrotubular properties.
Methods and findings in experimental and clinical pharmacology 1985;7(4):183-7.
-
1985: Richard C; Mahboub S; Delacourte A; Hemon B; Han K K
Comparative studies of the neurofilament triplet protein peptide mapping by chemical cleavage.
Comparative biochemistry and physiology. B, Comparative biochemistry 1985;80(4):707-12.
-
1985: Persuy P; Defossez A; Delacourte A; Tramu G; Bouchez B; Arnott G
Anti-PHF antibodies: an immunohistochemical marker of the lesions of the Alzheimer's disease. Characterization and comparison with Bodian's silver impregnation.
Virchows Archiv. A, Pathological anatomy and histopathology 1985;407(1):13-23.
-
1984: Mallevais M L; Delacourte A; Luyckx M; Cazin M; Brunet C; Lesieur D
Antimicrotubular effects of ethacrynic acid.
Methods and findings in experimental and clinical pharmacology 1984;6(11):675-7.
-
1984: Mallevais M L; Delacourte A; Lesieur I; Lesieur D; Cazin M; Brunet C; Luyckx M
2-(4-methyl-1-piperazinylmethyl) acrylophenone dihydrochloride: a new antimicrotubular drug.
Biochimie 1984;66(6):477-82.
-
1984: Francois C; Delacourte A; Han K K; Mazzuca M
Accessibility and cross-linking of native neurofilaments to chemical reagents.
The International journal of biochemistry 1984;16(5):461-7.
-
1982: Delacourte A; Dousti M; Loucheux-Lefebvre M H
Characterization of mammalian neurofilament subunits by circular dichroism.
Biochimica et biophysica acta 1982;709(1):99-104.
-
1982: Prochiantz A; Delacourte A; Daguet M C; Paulin D
Intermediate filament proteins in mouse brain cells cultured in the presence or absence of fetal calf serum.
Experimental cell research 1982;139(2):404-10.
-
1981: Filliatreau G; Di Giamberardino L; Delacourte A; Boutteau F; Biserte G
[Polypeptide composition of neurofilaments of birds]
Biochimie 1981;63(4):369-71.
-
1981: Plancke Y; Delacourte A; Biserte G
Preparation of neurofilaments from three different sources.
Biochimie 1981;63(4):365-7.
-
1980: Delacourte A; Filliatreau G; Boutteau F; Biserte G; Schrevel J
Study of the 10-nm-filament fraction isolated during the standard microtubule preparation.
The Biochemical journal 1980;191(2):543-6.
-
1979: Thorpe R; Delacourte A; Ayers M; Bullock C; Anderton B H
The polypeptides of isolated brain 10nm filaments and their association with polymerized tubulin.
The Biochemical journal 1979;181(2):275-84.
-
1979: Thorpe R; Delacourte A; Anderton B H
The isolation of brain 10 nm filament polypeptides from urea-extracts of brain white matter.
FEBS letters 1979;103(1):148-51.
-
1978: Colombo P; Conte U; Caramella C; La Manna A; Guyot J C; Delacourte A; Devise B; Traisnel M; Boniface M
The relevance of viscous behaviour to stress/displacement relationship in pharmaceutical powders compression.
Il Farmaco; edizione pratica 1978;33(12):531-42.
-
1977: Delacourte A; Plancot M T; Han K K; Hildebrand H; Biserte G
Investigation of tubulin fibers formed during microtubule polymerization cycles.
FEBS letters 1977;77(1):41-6.
-
1977: Delacourte A; Plancot M T; Boutteau F; Han K K; Hildebrand H F; Biserte G
[Preparation of highly purified microbules and evidence for a novel molecular arrangement at low temperatures]
Biochimie 1977;59(5-6):479-86.
-
1973: Delacourte A; Han K K; Dautrevaux M
[Alkylation of histidine residues of horse myoglobin. Study of 1-CM His-113 myoglobin]
Biochimie 1973;55(8):869-76.
Sign-in to see more
